149 related articles for article (PubMed ID: 15238073)
1. Lupus glomerulonephritis revisited 2004: autoimmunity and end-organ damage.
Bagavant H; Deshmukh US; Gaskin F; Fu SM
Scand J Immunol; 2004; 60(1-2):52-63. PubMed ID: 15238073
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of lupus disease by anti-double-stranded DNA antibodies of the IgM isotype in the (NZB x NZW)F1 mouse.
Werwitzke S; Trick D; Kamino K; Matthias T; Kniesch K; Schlegelberger B; Schmidt RE; Witte T
Arthritis Rheum; 2005 Nov; 52(11):3629-38. PubMed ID: 16255055
[TBL] [Abstract][Full Text] [Related]
3. Cross-reactivity of human lupus anti-DNA antibodies with alpha-actinin and nephritogenic potential.
Zhao Z; Weinstein E; Tuzova M; Davidson A; Mundel P; Marambio P; Putterman C
Arthritis Rheum; 2005 Feb; 52(2):522-30. PubMed ID: 15693007
[TBL] [Abstract][Full Text] [Related]
4. Susceptibility of mast cell-deficient W/Wv mice to pristane-induced experimental lupus nephritis.
Lin L; Gerth AJ; Peng SL
Immunol Lett; 2004 Feb; 91(2-3):93-7. PubMed ID: 15019275
[TBL] [Abstract][Full Text] [Related]
5. BAFF overexpression and accelerated glomerular disease in mice with an incomplete genetic predisposition to systemic lupus erythematosus.
Stohl W; Xu D; Kim KS; Koss MN; Jorgensen TN; Deocharan B; Metzger TE; Bixler SA; Hong YS; Ambrose CM; Mackay F; Morel L; Putterman C; Kotzin BL; Kalled SL
Arthritis Rheum; 2005 Jul; 52(7):2080-91. PubMed ID: 15986357
[TBL] [Abstract][Full Text] [Related]
6. Induction of systemic lupus erythematosus-like syndrome in syngeneic mice by immunization with activated lymphocyte-derived DNA.
Qiao B; Wu J; Chu YW; Wang Y; Wang DP; Wu HS; Xiong SD
Rheumatology (Oxford); 2005 Sep; 44(9):1108-14. PubMed ID: 15840592
[TBL] [Abstract][Full Text] [Related]
7. DNA hypomethylation is crucial for apoptotic DNA to induce systemic lupus erythematosus-like autoimmune disease in SLE-non-susceptible mice.
Wen ZK; Xu W; Xu L; Cao QH; Wang Y; Chu YW; Xiong SD
Rheumatology (Oxford); 2007 Dec; 46(12):1796-803. PubMed ID: 18032537
[TBL] [Abstract][Full Text] [Related]
8. Enhanced susceptibility to end-organ disease in the lupus-facilitating NZW mouse strain.
Xie C; Zhou XJ; Liu X; Mohan C
Arthritis Rheum; 2003 Apr; 48(4):1080-92. PubMed ID: 12687552
[TBL] [Abstract][Full Text] [Related]
9. Association of alpha-actinin-binding anti-double-stranded DNA antibodies with lupus nephritis.
Renaudineau Y; Croquefer S; Jousse S; Renaudineau E; Devauchelle V; Guéguen P; Hanrotel C; Gilburd B; Saraux A; Shoenfeld Y; Putterman C; Youinou P
Arthritis Rheum; 2006 Aug; 54(8):2523-32. PubMed ID: 16868973
[TBL] [Abstract][Full Text] [Related]
10. Anti-DNA antibody subpopulations and lupus nephritis.
Rekvig OP; Kalaaji M; Nossent H
Autoimmun Rev; 2004 Feb; 3(2):1-6. PubMed ID: 15003181
[TBL] [Abstract][Full Text] [Related]
11. Exposure of chromatin and not high affinity for dsDNA determines the nephritogenic impact of anti-dsDNA antibodies in (NZBxNZW)F1 mice.
Mjelle JE; Kalaaji M; Rekvig OP
Autoimmunity; 2009 Feb; 42(2):104-11. PubMed ID: 19005880
[TBL] [Abstract][Full Text] [Related]
12. TLR9 and TLR4 are required for the development of autoimmunity and lupus nephritis in pristane nephropathy.
Summers SA; Hoi A; Steinmetz OM; O'Sullivan KM; Ooi JD; Odobasic D; Akira S; Kitching AR; Holdsworth SR
J Autoimmun; 2010 Dec; 35(4):291-8. PubMed ID: 20810248
[TBL] [Abstract][Full Text] [Related]
13. Nephritogenic potential of anti-DNA antibodies against necrotic nucleosomes.
Mortensen ES; Rekvig OP
J Am Soc Nephrol; 2009 Apr; 20(4):696-704. PubMed ID: 19329762
[TBL] [Abstract][Full Text] [Related]
14. Lupus autoantibodies to native DNA preferentially bind DNA presented on PolIV.
Kumar S; Bunting KA; Kalsi J; Hinks JA; Latchman DS; Pearl LH; Isenberg DA
Immunology; 2005 Mar; 114(3):418-27. PubMed ID: 15720443
[TBL] [Abstract][Full Text] [Related]
15. Treatment of lupus-prone NZB/NZW F1 mice with recombinant soluble Fc gamma receptor II (CD32).
Werwitzke S; Trick D; Sondermann P; Kamino K; Schlegelberger B; Kniesch K; Tiede A; Jacob U; Schmidt RE; Witte T
Ann Rheum Dis; 2008 Feb; 67(2):154-61. PubMed ID: 17557887
[TBL] [Abstract][Full Text] [Related]
16. Anti-DNA antibodies in the pathogenesis of lupus nephritis--the emerging mechanisms.
Yung S; Chan TM
Autoimmun Rev; 2008 Feb; 7(4):317-21. PubMed ID: 18295737
[TBL] [Abstract][Full Text] [Related]
17. NZM2328: a new mouse model of systemic lupus erythematosus with unique genetic susceptibility loci.
Waters ST; Fu SM; Gaskin F; Deshmukh US; Sung SS; Kannapell CC; Tung KS; McEwen SB; McDuffie M
Clin Immunol; 2001 Sep; 100(3):372-83. PubMed ID: 11513551
[TBL] [Abstract][Full Text] [Related]
18. The role of positive feedback loops involving anti-dsDNA and anti-anti-dsDNA antibodies in autoimmune glomerulonephritis.
Arazi A; Neumann AU
J Theor Biol; 2013 Feb; 319():8-22. PubMed ID: 23142592
[TBL] [Abstract][Full Text] [Related]
19. Chemokine receptor Ccr2 deficiency reduces renal disease and prolongs survival in MRL/lpr lupus-prone mice.
Pérez de Lema G; Maier H; Franz TJ; Escribese M; Chilla S; Segerer S; Camarasa N; Schmid H; Banas B; Kalaydjiev S; Busch DH; Pfeffer K; Mampaso F; Schlöndorff D; Luckow B
J Am Soc Nephrol; 2005 Dec; 16(12):3592-601. PubMed ID: 16267157
[TBL] [Abstract][Full Text] [Related]
20. Failure of CD25+ T cells from lupus-prone mice to suppress lupus glomerulonephritis and sialoadenitis.
Bagavant H; Tung KS
J Immunol; 2005 Jul; 175(2):944-50. PubMed ID: 16002693
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
